When compared with its level in normal breast, FAM83A shows an increased expression in both breast tumors and, to a greater extent, in early phase of BC development, as suggested by our data on susceptible normal breast and Aran et al.’s data on NAT [24]. This evidence concerns the gene BRD2 and breast cancer.